1. Natural compounds and extracts from Mexican medicinal plants with anti-leishmaniasis activity: An update
Gabriel Alfonso GUTIÉRREZ-REBOLLEDO ; Susan DRIER-JONAS ; María Adelina JIMÉNEZ-ARELLANES
Asian Pacific Journal of Tropical Medicine 2017;10(12):1105-1110
Leishmaniasis is considered as an emerging, uncontrolled disease and is endemic in 98 countries. Annually, about 2 million cases of cutaneous and 500 000 cases of visceral-type leishmaniasis are recorded and 60 000 persons died from the disease. In Mexico, cutaneous leishmaniasis is known as chiclero's ulcer and is reported in 22 states, it is considered as a health problem. For its treatment, pentavalent antimonial drugs are administered. These drugs cause severe side effects, are costly. Drug-resistant cases have been reported and have been developing for over 70 years. One alternative to the drugs that are currently available is to find active molecules in medicinal plants. Dihydrocorynantheine, corynantheine and corynantheidine are active against Leishmania major, while harmane, pleiocarpin, buchtienin, luteolin and quercetin are active against Leishmania donovani. In Mexico, about 20 medicinal plants have been evaluated against Leishmania mexicana, among which the most active are Tridax procumbens, Lonchocarpus xuul and Pentalinon andrieuxii. From these plants, active compounds with IC
2. Anti-inflammatory evaluation and acute toxicity of three food supplements that contain Moussonia deppeana
Gabriel Alfonso GUTIÉRREZ-REBOLLEDO ; Mariana Zuleima PÉREZ-GONZÁLEZ ; María Adelina JIMÉNEZ-ARELLANES ; Alejandro ZAMILPA
Asian Pacific Journal of Tropical Medicine 2017;10(2):141-147
Objective To identify the anti-inflammatory activity through two murine models and in the median Lethal Dose (LD
3. Medical plant extracts and natural compounds with a hepatoprotective effect against damage caused by antitubercular drugs: A review
María Adelina JIMÉNEZ-ARELLANES ; Gabriel Alfonso GUTIÉRREZ-REBOLLEDO ; Mariana MECKES-FISCHER ; Rosalba LEÓN-DÍAZ
Asian Pacific Journal of Tropical Medicine 2016;9(12):1141-1149
Drug-induced liver injury encompasses a spectrum of diseases ranging from mild biochemical abnormalities to acute liver failure; example of this scenery is hepatotoxicity caused by the first-line antituberculous drugs isoniazid, rifampin and pyrazinamide, which are basic for treatment of drug-sensible and drug-resistant tuberculosis. In the search for pharmacological alternatives to prevent liver damage, antitubercular drugs have been the subject of numerous studies and published reviews, a great majority of them carried out by Asian countries. At the same time, hepatoprotectors from plant source are now emerging as a possible alternative to counteract the toxic effects of these therapeutic agents. The present review aims to highlight the most recent studies on the subject, based information published in scientific databases such as Scopus and PubMed.